Literature DB >> 30119270

miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.

Li Luo1, Li Xia1, Binshan Zha2, Chunlin Zuo1, Datong Deng1, Mingwei Chen1, Linhong Hu1, Yong He1, Fang Dai1, Jing Wu3, Changjiang Wang1, Youmin Wang1, Qiu Zhang4.   

Abstract

miRNAs is a kind of noncoding small RNAs with negative regulation function. Some miRNAs play a crucial role in the growth of tumor cells. In this study, we analyzed the role of miR-335-5p and its target gene intercellular adhesion molecule 1 (ICAM-1) in thyroid cancer. Real-time polymerase chain reaction (PCR) results showed that the expression level of ICAM-1 in cancer tissues was higher than that in their adjacent tissues. The expression level of ICAM-1 in papillary thyroid carcinoma was also significantly higher than that in other types of tumors. However, the expression of miR-335-5p is opposite to that of ICAM-1. In human thyroid cancer cell lines TPC-1, FTC-133, TT and human thyroid follicular cell line Nthyori 3-1, the expression level of ICAM-1 in TPC-1 was significantly higher than that of other cells, while the expression level of miR-335-5p in TPC-1 was significantly lower than that of other cells. When ICAM-1 expression was downregulated and miR-335-5p expression was upregulated in TPC-1 cells, ICAM-1 expression was upregulated and miR-335-5p expression was downregulated in FTC-133 cells, we found that ICAM-1 could promote the proliferation of thyroid cancer cells, while miR-335-5p could inhibit the proliferation of thyroid cancer cells. miR-335-5p could combine with 3'UTR of ICAM-1 by bioinformatics prediction. Luciferase reporter gene analysis and Western blotting detection further confirmed that miR-335-5p could target ICAM-1 and inhibit its expression. The expression level of miR-335-5p was downregulated, while the expression level of ICAM-1 was upregulated in thyroid cancer. This study will help us better understand the pathogenesis of thyroid cancer and provide new insights into the treatment of this disease.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ICAM-1; Thyroid cancer; miR-335-5p; miRNAs

Mesh:

Substances:

Year:  2018        PMID: 30119270     DOI: 10.1016/j.biopha.2018.07.046

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  27 in total

1.  LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.

Authors:  Meihua Liang; Jinliang Jia; Lili Chen; Biyue Wei; Qiang Guan; Zhaoming Ding; Jiawei Yu; Rui Pang; Guoqing He
Journal:  Endocrine       Date:  2019-04-27       Impact factor: 3.633

2.  Extracellular vesicles carrying proinflammatory factors may spread atherosclerosis to remote locations.

Authors:  Mengna Peng; Rui Sun; Ye Hong; Jia Wang; Yi Xie; Xiaohao Zhang; Juanji Li; Hongquan Guo; Pengfei Xu; Yunzi Li; Xiaoke Wang; Ting Wan; Ying Zhao; Feihong Huang; Yuhui Wang; Ruidong Ye; Qian Liu; George Liu; Xinfeng Liu; Gelin Xu
Journal:  Cell Mol Life Sci       Date:  2022-07-18       Impact factor: 9.207

3.  Long Noncoding RNA CCDC26 Promotes Thyroid Cancer Malignant Progression via miR-422a/EZH2/Sirt6 Axis.

Authors:  Xiao Ma; Yanyan Li; Yuntao Song; Guohui Xu
Journal:  Onco Targets Ther       Date:  2021-05-11       Impact factor: 4.147

4.  Thymosin β10 mediates the effects of microRNA-184 in the proliferation and epithelial-mesenchymal transition of BCPAP cells.

Authors:  Cheng Yang; Yunni Liu; Kun Fang
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

5.  Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases.

Authors:  Chen Lu; Xiagang Luo; Cheng Xing; Yonghuan Mao; Yuting Xu; Wenjie Gao; Wulin Wang; Tian Zhan; Guoguang Wang; Zhengxia Liu; Chunzhao Yu
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

6.  miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2.

Authors:  Xiyong Wang; Huaiqing Xiao; Dongqiang Wu; Dongliang Zhang; Zhihao Zhang
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

7.  GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma.

Authors:  Wang Zhang; Zhendong Liu; Binchao Liu; Miaomiao Jiang; Shi Yan; Xian Han; Hong Shen; Meng Na; Yanbiao Wang; Zhishuai Ren; Binfeng Liu; Zhenfeng Jiang; Yanzheng Gao; Zhiguo Lin
Journal:  Cancer Cell Int       Date:  2021-06-07       Impact factor: 5.722

8.  Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.

Authors:  Bin Pan; Xiangbo Bu; Menghan Cao; Xin Zhang; Tianqun Huo; Ziang Li; Xiao Gao; Li Jing; Xuanxiang Luo; Hu Feng; Feng Yuan; Kaijin Guo
Journal:  J Cancer Res Clin Oncol       Date:  2020-10-26       Impact factor: 4.553

9.  Circular RNA Circ_0067934 Attenuates Ferroptosis of Thyroid Cancer Cells by miR-545-3p/SLC7A11 Signaling.

Authors:  Hui-Hui Wang; Jia-Ni Ma; Xiao-Rong Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

10.  Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.

Authors:  Jintao Qian; Xinhan Lei; Yue Sun; Lu Zheng; Jia Li; Shuai Zhang; Lei Zhang; Wanwan Li; Jianing Shi; Wenjun Jia; Tong Tang
Journal:  Biol Direct       Date:  2021-08-06       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.